Helen D. Sage

Helen D. Sage

Auto-generated profile, based on publicly available information

Helen D. Sage

Oxford Medical Genetics Laboratories, Churchill Hospital, Oxford, United Kingdom (M.B., J.B.G.H., H.S., C.C., B.C., K.M., K.S., K.L.T.).

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2005 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
JDJohn J. Dooley
John J. Dooley
HSHelen D. Sage
Helen D. Sage
MCMarie-Anne L. Clarke
Marie-Anne L. Clarke
HBHelen M. Brown
Helen M. Brown
SGStephen D. Garrett
Stephen D. Garrett

1 September 2005 in Food Control
Verified
Journal Article
Closed access
JDJohn J. Dooley
John J. Dooley
HSHelen D. Sage
Helen D. Sage
HBHelen M. Brown
Helen M. Brown
SGStephen D. Garrett
Stephen D. Garrett

1 June 2020 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
PDF file
AHAndrew R. Harper
Andrew R. Harper
MBMichael Bowman
Michael Bowman
JHJesse B.G. Hayesmoore
Jesse B.G. Hayesmoore
HSHelen Sage
Helen Sage
SSSilvia Salatino
Silvia Salatino
KTKate L. Thomson
Kate L. Thomson
Background: The common intronic deletion, MYBPC3 Δ25 , detected in 4% to 8% of South Asian populations, is reported to be associated with cardiomyopathy, with ≈7-fold increased risk of disease in variant carriers. Here, we examine the contribution of MYBPC3 Δ25 to hypertrophic cardiomyopathy (HCM) in a large patient cohort. Methods: Sequence data from 2 HCM cohorts (n=5393) was analyzed to determine MYBPC3 Δ25 frequency and co-occurrence of pathogenic variants in HCM genes. Case-control and haplotype analyses were performed to compare variant frequencies and assess disease association. Analyses were also undertaken to investigate the pathogenicity of a candidate variant MYBPC3 c.1224-52G>A. Results: Our data suggest that the risk of HCM, previously attributed to MYBPC3 Δ25 , can be explained by enrichment of a derived haplotype, MYBPC3 Δ25/ −52 , whereby a small subset of individuals bear both MYBPC3 Δ25 and a rare pathogenic variant, MYBPC3 c.1224-52G>A. The intronic MYBPC3 c.1224-52G>A variant, which is not routinely evaluated by gene panel or exome sequencing, was detected in ≈1% of our HCM cohort. Conclusions: The MYBPC3 c.1224-52G>A variant explains the disease risk previously associated with MYBPC3 Δ25 in the South Asian population and is one of the most frequent pathogenic variants in HCM in all populations; genotyping services should ensure coverage of this deep intronic mutation. Individuals carrying MYBPC3 Δ25 alone are not at increased risk of HCM, and this variant should not be tested in isolation; this is important for the large majority of the 100 million individuals of South Asian ancestry who carry MYBPC3 Δ25 and would previously have been declared at increased risk of HCM.

1 January 2005 in Primary Dental Care
Verified
Journal Article
Open access
Shahid AnwarShahid Anwar
Shahid Anwar
SWSonia A Williams
Sonia A Williams
JSJennifer Scott-Smith
Jennifer Scott-Smith
HSHelen Sage
Helen Sage
SBSohrab Baweja
Sohrab Baweja
NSNaresh Sharma
Naresh Sharma
Aims and objectives: As part of a student elective, this pilot study aimed at investigating attitudes and practices concerning gutka use in a town in India. It was hoped that information gained would assist in formulating an appropriate health education programme to encourage gutka cessation locally and would provide more information about a habit which is also relevant to some UK South Asian populations. Design and setting: 124 consecutively attending subjects (103 males and 21 females) at a charity-run dental clinic in Chitrakoot, India, were interviewed using a semi-structured questionnaire. Main findings: 57 (46%) of the respondents, of whom there were more males than females (103 v. 21), reported current gutka use. There were no differences between users and non-users by age or educational attainment. Users found gutka ‘helpful’ in relieving tension, aiding concentration, combating bad breath and as a leisure activity. They all cited other family members who were using gutka as compared to only 40% of the gutka non-users. Cancer was mentioned as a harmful outcome of gutka use more frequently by non-users. Of the 57 gutka chewers, 36 also chewed paan with tobacco and 20 smoked cigarettes. Conclusions: Gutka chewing involved almost half of the study population and proportionately more males than females. The habit was endemic within families. Many gutka chewers also smoked, chewed paan or drank alcohol, representing a high-risk behaviour for oral cancer. Proportionately more non-chewers were aware of the link with cancer. There are clear implications for health promotion in India. General dental practitioners in the UK should also be aware of the possibility that this habit is becoming more widely adopted in South Asian communities here, involving young children as well as adults. Research into gutka use is also required in the UK.